Surgical Sutures Market (2026 - 2033) Size, Share & Trends Analysis Report By Type (Absorbable, Non-absorbable), By Filament (Monofilament, Multifilament), By Application (General Surgery, Cardiovascular Surgery), By Region, And Segment Forecasts

Surgical Sutures Market Summary

The global surgical sutures market size was estimated at USD 5.02 billion in 2025 and is projected to reach USD 7.41 billion by 2033, growing at a CAGR of 4.98% from 2026 to 2033. The market is primarily driven by the rising volume of surgical procedures worldwide, fueled by the increasing prevalence of chronic diseases and an aging population requiring surgical interventions.

In addition, advancements in suture materials, such as antimicrobial and absorbable sutures, enhance patient outcomes and reduce infection risks, further boosting adoption. Growing healthcare infrastructure and access to surgical care in emerging economies also contribute significantly to market expansion.

The demand for wound closure products is rising owing to the growing number of surgical cases and the increasing prevalence of chronic wounds across the globe. According to the data published by Onenessbio in May 2025, approximately 6.3% of adults with diabetes worldwide suffer from diabetic foot ulcer (DFU). Such a burden of chronic wounds is anticipated to propel the demand for wound closure devices in the coming years. In addition, the rising incidence of road traffic accidents worldwide is expected to significantly drive the growth of the wound closure devices market.

Diabetes-Related Foot Ulcers (DFU) Burden in Australia

Source: NCBI

Traffic-related injuries often result in severe wounds and trauma that require surgical intervention and effective wound management. According to the Global Road Safety Facility (GRSF) Annual Report 2024, road crashes claim approximately 1.19 million lives each year and lead to countless severe injuries and long-term disabilities globally. This alarming rate of injuries creates a substantial demand for advanced wound closure solutions. As the burden of traumatic injuries increases, healthcare providers and surgical centers are increasingly seeking reliable and efficient wound closure products to improve patient outcomes and reduce recovery times. Therefore, the growing prevalence of traffic-related injuries is expected to be a key driver supporting the expansion of the wound closure devices market in the coming years.

The growing number of surgical procedures worldwide is a significant factor driving the expansion of the surgical sutures industry. According to data published by Wellcome Leap Inc. in June 2024, approximately 313 million surgeries are performed annually across the globe. An estimated 143 million additional procedures are also needed each year to meet essential healthcare needs, particularly in low-resource regions. Most traumatic or surgical wounds require some form of skin closure. Generally, this closure is done by suturing. Therefore, the rising demand for surgical interventions is expected to fuel the growth of surgical sutures in the coming years.

Source: World Population Review

Common surgeries, including cataract operations, corneal transplantation (keratoplasty), and orthopedic procedures like total knee replacements, require surgical sutures. According to data published by the Cleveland Clinic, in October 2025, approximately 185,000 cornea transplant (keratoplasty) surgeries were conducted annually worldwide. As surgical activity continues to rise worldwide, the need for reliable surgical suture solutions is expected to grow accordingly.

Technological advancements are driving the surgical sutures market through innovations such as antimicrobial-coated sutures (e.g., triclosan-coated variants) that help reduce surgical site infections, and barbed sutures that eliminate the need for knotting, improving surgical efficiency. In addition, the development of synthetic absorbable sutures, such as polyglycolic acid (PGA) and polydioxanone (PDO), enables controlled degradation and improved healing outcomes, supporting their increasing adoption in modern surgical procedures.

Market Concentration & Characteristics

The market growth stage is moderate, and the pace of the market growth is accelerating due to advancements in medical technology and materials used in sutures, which have led to enhanced product efficacy, driving product adoption and demand. Furthermore, the rising prevalence of chronic diseases and age-related ailments necessitating surgical interventions, coupled with a growing global population, contributes significantly to the expanding market.

The degree of innovation in the surgical sutures market is moderate to high, driven by continuous advancements in material science and wound care technologies. Manufacturers are developing absorbable, antimicrobial, and barbed sutures that improve healing efficiency, reduce infection risks, and eliminate the need for knotting. Innovations are also focused on enhancing biocompatibility and tensile strength while minimizing tissue reaction. In addition, integration with advanced surgical techniques, including minimally invasive procedures, is further pushing product development. For instance, In July 2025, Smith & Nephew announced the release of its Q-FIX KNOTLESS All-Suture Anchor, designed for soft tissue-to-bone fixation across multiple joint areas, including the shoulder, hip, and foot & ankle.

"When I think of the Q-FIX family I think of reliability,” commented Dr. Robert Litchfield, Orthopedic Surgeon, Sports Medicine Ontario, Canada. “We know that when we put a Q-FIX Anchor in, that we can count on it - the deployment is always predictable and the pullouts are impressive. In my experience, these anchors just don't fail when we put load on them."

The level of mergers and acquisitions in the surgical sutures market is moderate, with leading medical device companies actively pursuing strategic deals to strengthen their product portfolios and global presence. Larger players often acquire smaller firms with specialized technologies, such as advanced or antimicrobial sutures, to enhance innovation capabilities. These activities also help companies expand into emerging markets and improve distribution networks. The M&A trends are driven by the need for technological advancement, competitive positioning, and geographic expansion. For instance, In June 2024, Riverpoint Medical, a developer, designer, and manufacturer of medical devices focused on advanced surgical fiber and regenerative technologies, announced the completion of its acquisition of C.P. Medical Corporation. Riverpoint is a portfolio company of Arlington Capital Partners, a Washington, D.C.-based private equity firm specializing in government-regulated industries.

Regulations have a significant impact on the surgical sutures market, as products must meet strict safety, quality, and biocompatibility standards before approval. Compliance with frameworks such as FDA medical device regulations and the EU Medical Device Regulation (MDR) increases development timelines and costs for manufacturers. However, these regulations also ensure product reliability and patient safety, which builds trust among healthcare providers. In addition, evolving regulatory requirements are encouraging continuous innovation and improved product standards across the market.

End use concentration in the surgical sutures market is relatively high, with hospitals accounting for the largest share due to the high volume of inpatient and complex surgical procedures. Ambulatory surgical centers are also growing as key end users, driven by the shift toward minimally invasive and same-day surgeries. Clinics and specialty care settings contribute a smaller share, mainly for minor procedures. The demand remains concentrated in institutional healthcare settings with established surgical infrastructure.

Type Insights

The absorbable segment dominated the market in 2025 and is expected to record the fastest CAGR over the forecast period. The demand for absorbable sutures is steadily increasing due to their ability to temporarily support wounds until they heal and withstand normal stress. In addition, absorbable sutures naturally degrade, making them a preferred choice. The composition of absorbable sutures plays a significant role in their market dominance. These sutures are made from natural material, such as catgut, or synthetic polymers, including polyglycolic acid, polylactic acid, and polydioxanone. The body enzymatically degrades natural sutures, whereas synthetic variants undergo hydrolytic degradation. This gradual absorption ensures that the sutures provide adequate tissue support during the critical healing period and are fully absorbed without requiring removal, thereby reducing patient discomfort and the risk of infection. In July 2025, Corza Medical expanded its Onatec Ophthalmic Suture Portfolio, offering nearly 130 products designed exclusively for delicate ophthalmic and oculoplastic surgeries. The portfolio includes absorbable and non-absorbable sutures made from highly tempered stainless steel.

The non-absorbable segment is projected to grow significantly over the forecast period, due to its long-lasting nature and sustained demand for various surgical procedures. Their durability and effectiveness drive this rise in popularity, contributing to their lucrative expansion in the market.

Filament Insights

The multifilament segment accounted for the largest market share in 2025. This can be attributed to the advantages associated with multifilament, such as better compliance, high tensile strength, and flexibility.

The monofilament segment is projected to grow at the fastest CAGR over the forecast period. Its single-strand design offers reduced tissue trauma and improved handling during surgery. The increasing preference for monofilament sutures is attributed to their decreased risk of infection and tissue reaction, contributing significantly to their expanding market share.

Application Insights

The general surgery segment held the largest share of the market in 2025, driven by the widespread use of surgical sutures as therapeutic agents to prevent and treat thromboembolic disorders. This segment includes plasma-derived and recombinant surgical sutures products, which are essential for managing hereditary surgical sutures deficiency, deep vein thrombosis, and complications during major surgeries.

The cardiovascular segment is anticipated to register the fastest growth over the forecast period, due to the high incidence of cardiac diseases, sufficient experts in the field, supportive reimbursement scenarios, and advanced diagnostics. According to the report, “Global Cardiac Surgical Volume and Gaps: Trends, Targets, and Way Forward”, published in Annals of Thoracic Surgery Short Reports in 2024, high-income countries performed an average of 123.2 cardiac surgical procedures per 100,000 people annually. When adjusted for cardiovascular disease burden, recommended annual volumes are 86.1 per 100,000 in upper-middle-income countries, 55.1 in lower-middle-income countries, and 40.2 in low-income countries. These targets are intended to guide the planning and scaling up of cardiac surgical capacity in alignment with population needs and universal health coverage goals.

Regional Insights

North America surgical sutures market dominated the global industry and accounted for 44.06% share in 2025, owing to the strong presence of major local and international companies, which led to the development of innovative products and extensive distribution networks. In addition, the relatively higher cost of sutures compared to other regions, supportive reimbursement policies, and government healthcare programs created a favorable environment for sustained market growth.

U.S. Surgical Sutures Market Trends

The U.S. surgical sutures industry accounted for the largest share in North America in 2025. This is due to strong healthcare infrastructure, extensive research and development activities, and the presence of major healthcare players and manufacturers within its borders. In addition, the U.S. healthcare system's emphasis on innovation, high healthcare expenditures, and favorable reimbursement policies further help its prominent share in the market. The U.S. has an increasing geriatric population, which is more prone to chronic conditions requiring surgical intervention. Older adults often require procedures for cardiovascular, orthopedic, and ophthalmic issues, which drives consistent demand for high-quality sutures. As the elderly population rises, the market sees a sustained need for surgical sutures capable of delivering reliable performance in delicate or complex surgeries, fueling overall market growth.

Europe Surgical Sutures Market Trends

The Europe surgical sutures industry is expected to witness significant growth in the coming years, driven by the increasing number of surgical procedures due to the rising prevalence of chronic diseases, an aging population, and the expansion of healthcare infrastructure across the region. Technological advancements, such as antimicrobial-coated, biodegradable, and precision sutures for robotic-assisted surgeries, enhance patient outcomes and reduce post-operative complications. In addition, the growing adoption of minimally invasive and robotic-assisted surgeries is boosting the demand for advanced suturing solutions that offer greater efficiency and accuracy.

The UK surgical sutures market is showing stable growth, supported by high volumes of surgical procedures in the public healthcare system and increasing demand for efficient wound closure solutions. There is a clear trend toward the use of advanced sutures, including absorbable and antimicrobial types, to enhance recovery and reduce infection risks. In addition, the growing adoption of minimally invasive surgeries is driving demand for precision suturing products. Emphasis on cost-effectiveness and standardized clinical practices is also shaping product selection across healthcare settings.

The France surgical sutures market is experiencing consistent growth, driven by a high number of surgical procedures and a strong public healthcare system that ensures broad access to care. There is an increasing preference for advanced sutures, such as absorbable and antibacterial types, to enhance healing outcomes and reduce complications. The rising adoption of minimally invasive surgeries is also influencing demand for precision suturing solutions. In addition, emphasis on quality standards and clinical efficiency continues to shape product usage across hospitals and surgical centers.

Asia Pacific Surgical Sutures Market Trends

The APAC surgical sutures market is witnessing strong growth driven by rising surgical volumes, fueled by the increasing prevalence of chronic diseases and a rapidly aging population in countries such as China, India, and Japan. Expanding healthcare infrastructure and improving access to surgical care, particularly in emerging economies, are key trends supporting demand. In addition, there is a growing shift toward advanced sutures, including absorbable and antimicrobial variants, due to their ability to enhance healing and reduce infection risks. The region is also seeing increased local manufacturing and cost-competitive products, making sutures more accessible across diverse healthcare settings.

The Japanese surgical sutures market is primarily driven by the country’s rapidly aging population. As of September 2024, 29.3% of Japan’s population is aged 65 and older, the highest proportion globally. The geriatric population is more susceptible to chronic wounds, complications from underlying diseases, and slower recovery post-surgery, leading to increased hospitalizations and surgical interventions. This demographic trend significantly boosts the demand for reliable and advanced surgical sutures to ensure effective wound closure and minimize post-operative complications.

The China surgical sutures market is experiencing significant growth, largely driven by demographic trends. The country’s rapidly aging population is contributing to a higher prevalence of chronic diseases such as cardiovascular conditions, diabetes, and other age-related health issues, which often require surgical interventions. This increase in surgery demand directly fuels the need for absorbable and non-absorbable surgical sutures across hospitals and specialty clinics.

Number of surgical procedures (per 100,000 population) - China in 2023

Source: World Bank Group

Latin America Surgical Sutures Market Trends

The Latin American surgical sutures industry is experiencing significant growth, primarily driven by increasing surgical procedures across the region. The rising prevalence of chronic diseases such as cardiovascular conditions, diabetes, and obesity has led to a higher demand for surgeries, thereby boosting the need for surgical sutures. Advancements in suture technology, including developing absorbable and specialized sutures, have improved surgical outcomes and safety, further supporting market expansion. In addition, investments in healthcare infrastructure and improved access to surgical services have facilitated greater adoption of sutures across hospitals and clinics, collectively contributing to the market’s growth trajectory.

Middle East & Africa Surgical Sutures Market Trends

The MEA surgical sutures market is experiencing significant growth, driven by rising surgical volumes due to a rise in chronic diseases and trauma-related injuries. Governments across the region are investing in healthcare infrastructure and expanding access to surgical care, particularly in urban centers.

A notable trend is the growing preference for advanced sutures, such as absorbable and antimicrobial types, to improve patient outcomes and reduce post-operative complications. In addition, the expansion of private healthcare providers and medical tourism in countries like the UAE and South Africa is further supporting market growth.

Key Surgical Sutures Company Insights

Some key companies in the market include Medtronic; Ethicon US, LLC.; B. Braun SE.; and others. Key players are taking several strategic initiatives, such as mergers and acquisitions, and partnerships with other major companies.

• B.Braun operates through three key divisions: Hospital Care, which focuses on infusion therapy, nutrition therapy, and pain management; Aesculap, specializing in surgical and interventional therapy solutions; and Avitum, which covers infection prevention, extracorporeal blood treatments, wound, stoma, and continence care. B. Braun offers a range of advanced wound care solutions, including Askina Calgitrol silver dressings, available in multiple forms to suit various wound care needs.

• Stryker provides innovative products and services across MedSurg, Neurotechnology, Orthopaedics, and Spine that aim to enhance patient outcomes and overall healthcare quality. In 2023, Stryker witnessed an organic sales growth of over 11%.

Recent Developments

• In July 2025, Smith+Nephew announced the launch of its Q-FIX KNOTLESS All-Suture Anchor, designed for soft tissue-to-bone fixation across various joint areas, including shoulder, hip, and foot and ankle.

• In July 2024, Corza Medical announced the successful acquisition of the TachoSil manufacturing operations in Linz, Austria, previously announced, integrating it into Takeda’s global production network. TachoSil is a world-renowned surgical patch trusted by healthcare professionals worldwide.

• In August 2023, Riverpoint Medical invested USD 10 million in a new manufacturing facility in the Coyol Free Trade Zone in Alajuela, Costa Rica. This strategic expansion aligns with the company’s goal of leveraging Costa Rica’s growing prominence as a hub for medical device manufacturing. The facility initially covers 4,000 square meters, featuring two certified clean rooms dedicated to producing absorbable and non-absorbable orthopedic sutures.

Surgical Sutures Market Report Scope

Global Surgical Sutures Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2030. For this study, Grand View Research has segmented the global surgical sutures market report based on type, filament, application, and region:

• Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Absorbable

  • Non-absorbable

• Filament Outlook (Revenue, USD Million, 2021 - 2033)

  • Monofilament

  • Multifilament

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • General Surgery

  • Ophthalmic Surgery

  • Cardiovascular Surgery

  • Orthopedic Surgery

  • Neurological Surgery

  • Others

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Sweden

    • Denmark

    • Norway

  • Asia Pacific

    • China

    • India

    • Japan

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait